Leucine Boosts Mitochondria via SEL1L Pathway
SkimNews Take
The discovery of leucine's role in protecting mitochondrial proteins suggests a fundamental mechanism by which dietary intake directly influences the efficiency and resilience of cellular powerhouses.
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- University of Cologne researchers found that leucine prevents the breakdown of proteins on mitochondria's outer membrane, allowing cells to generate energy more efficiently during nutrient abundance.
- Leucine suppresses activity of the protein SEL1L — part of the cell's quality-control system that normally marks damaged proteins for destruction — which is how outer-membrane mitochondrial proteins accumulate and function at higher levels.
- First author Dr. Qiaochu Li cautioned that SEL1L also plays a crucial role in preventing accumulation of damaged proteins essential for long-term cellular health, warning that any therapeutic strategy to boost leucine or suppress SEL1L must proceed carefully.
- Experiments in C. elegans roundworms showed that problems with leucine breakdown damaged mitochondrial function and caused fertility issues, broadening the finding's biological scope beyond human cells.
- Tests on human lung cancer cells revealed that cancer-related mutations affecting leucine metabolism appeared to improve cancer cell survival, pointing to a possible future target for oncology research.
- The study, published in Nature Cell Biology under the title 'Leucine inhibits degradation of outer mitochondrial membrane proteins to adapt mitochondrial respiration,' was led by Professor Dr. Thorsten Hoppe of the Institute for Genetics and the CECAD Cluster of Excellence on Aging Research.
- Funding came from Germany's Excellence Strategy through CECAD, multiple DFG-funded Collaborative Research Centres, an European Research Council Advanced Grant, and the Alexander von Humboldt Foundation.
Why it matters: The study gives drug developers a specific molecular handle — the leucine-SEL1L axis on outer mitochondrial membrane proteins — to explore for cancer and metabolic disease, but Li's warning that SEL1L clears damaged proteins means any boost to the pathway carries a tradeoff between short-term energy output and long-term cellular integrity.
